Data gathered: November 24
AI Stock Analysis - Dexcom (DXCM)
Analysis generated October 7, 2024. Powered by Chat GPT.
Dexcom, Inc. is a market leader in continuous glucose monitoring (CGM) systems for diabetes management. Founded in 1999 and headquartered in San Diego, California, Dexcom has focused on developing and marketing CGM devices for people with diabetes. The company's flagship product, the Dexcom G6, allows users to monitor their glucose levels in real time without the need for fingersticks. As a company that operates in the healthcare and medical technology sector, Dexcom is well-positioned to benefit from the increasing prevalence of diabetes worldwide and the shift towards more advanced, patient-friendly monitoring solutions.
Stock Alerts - Dexcom (DXCM)
 |
Dexcom | November 23 Insider Alert: Stern Sadie is selling shares |
|
Dexcom | November 19 AI Score is up by 34.2% in the last couple of days. |
|
Dexcom | November 19 Insider Alert: Sylvain Jereme M is selling shares |
|
Dexcom | November 15 AI Score is up by 33.8% in the last couple of days. |
Alternative Data for Dexcom
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 212 | Sign up | Sign up | Sign up |
| Sentiment | 79 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,506,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 46 | Sign up | Sign up | Sign up |
| Patents | 804 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 9,428 | Sign up | Sign up | Sign up |
| Facebook Followers | 194,313 | Sign up | Sign up | Sign up |
| Instagram Followers | 174,847 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 9 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 9,948 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,865 | Sign up | Sign up | Sign up |
| Twitter Mentions | 20 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 40,300 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 32 | Sign up | Sign up | Sign up |
| Business Outlook | 70 | Sign up | Sign up | Sign up |
| Linkedin Employees | 7,214 | Sign up | Sign up | Sign up |
About Dexcom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
| Price | $72.83 |
| Target Price | Sign up |
| Volume | 4,450,000 |
| Market Cap | $28.4B |
| Year Range | $64 - $140.45 |
| Dividend Yield | 0% |
| PE Ratio | 44.14 |
| Analyst Rating | 79% buy |
| Industry | Medical Devices |
In the news
 |
Banque Cantonale Vaudoise Has $791,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM)November 22 - ETF Daily News |
|
Mutual of America Capital Management LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)November 22 - ETF Daily News |
|
DexCom, Inc. (NASDAQ:DXCM) Receives $104.59 Average Target Price from AnalystsNovember 21 - ETF Daily News |
 |
Here’s Why DexCom (DXCM) Declined In Q3November 21 - Yahoo |
 |
Dexcom partners with Oura, invests $75M in ring makerNovember 21 - MobiHealthNews |
 |
Oura Partners With Dexcom to Bring Glucose Monitoring Data to Oura Smart Ring OwnersNovember 20 - Gadgets360.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 994M | 707M | 594M | 135M | 152M | 0.450 |
| Q2 '24 | 1B | 710M | 627M | 144M | 210M | 0.430 |
| Q1 '24 | 916M | 678M | 562M | 146M | 190M | 0.320 |
| Q4 '23 | 1.03B | 696M | 657M | 256M | 261M | 0.500 |
| Q3 '23 | 970M | 638M | 623M | 121M | 247M | 0.500 |
Insider Transactions View All
| Stern Sadie filed to sell 71,192 shares at $74.7. November 22 '24 |
| Sylvain Jereme M filed to sell 80,774 shares at $75.5. November 18 '24 |
| Heller Bridgette P filed to sell 24,349 shares at $70. September 17 '24 |
| Leach Jacob Steven filed to sell 264,915 shares at $69.2. September 11 '24 |
| Sylvain Jereme M filed to sell 84,274 shares at $69.2. September 11 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$90 0% | 58 |
 |
Edwards LifesciencesEW |
$70.48 0% | 54 |
 |
Intuitive SurgicalISRG |
$547.87 0% | 75 |
 |
MedtronicMDT |
$86.21 0% | 59 |
 |
StrykerSYK |
$384.85 0% | 71 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Oct 8, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Dexcom (DXCM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Dexcom?
The Market Cap of Dexcom is $28.4B.
What is Dexcom's PE Ratio?
As of today, Dexcom's PE (Price to Earnings) ratio is 44.14.
What is the current stock price of Dexcom?
Currently, the price of one share of Dexcom stock is $72.83.
How can I analyze the DXCM stock price chart for investment decisions?
The DXCM stock price chart above provides a comprehensive visual representation of Dexcom's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Dexcom shares. Our platform offers an up-to-date DXCM stock price chart, along with technical data analysis and alternative data insights.
Does DXCM offer dividends to its shareholders?
As of our latest update, Dexcom (DXCM) does not offer dividends to its shareholders. Investors interested in Dexcom should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Dexcom?
Some of the similar stocks of Dexcom are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.